Shield Therapeutics Plc (STX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 14,156 | 943 | 15,076 | 861 | 375 |
| Cost of Goods | 1,845 | 636 | 395 | 209 | 123 |
| Gross Profit | 12,310 | 307 | 14,681 | 651 | 252 |
| Operating Expenses | 15,246 | 12,153 | 21,239 | 28,965 | 15,625 |
| Operating Income | -2,936 | -11,846 | -6,558 | -28,313 | -15,373 |
| Interest Expense | 0 | 1 | 28 | N/A | 0 |
| Other Income | 365 | -39 | 47 | -58 | -3,878 |
| Pre-tax Income | -2,570 | -11,887 | -6,539 | -28,371 | -19,251 |
| Income Tax | 1,014 | -349 | -4,262 | -1,900 | -724 |
| Net Income Continuous | -3,584 | -11,538 | -2,276 | -26,471 | -18,527 |
| Net Income | $-3,584 | $-11,538 | $-2,276 | $-26,471 | $-18,527 |
| EPS Basic Total Ops | -0.03 | -0.10 | -0.02 | -0.22 | -0.18 |
| EPS Basic Continuous Ops | -0.03 | -0.10 | -0.02 | -0.22 | -0.18 |
| EPS Diluted Total Ops | -0.03 | -0.10 | -0.02 | -0.22 | -0.18 |
| EPS Diluted Continuous Ops | -0.03 | -0.10 | -0.02 | -0.22 | -0.18 |
| EBITDA(a) | $1,116 | $-8,449 | $-3,524 | $-25,020 | $-16,862 |